Kowa Pharmaceuticals America Revenue and Competitors
Estimated Revenue & Valuation
- Kowa Pharmaceuticals America's estimated annual revenue is currently $66.3M per year.
- Kowa Pharmaceuticals America's estimated revenue per employee is $201,000
Employee Data
- Kowa Pharmaceuticals America has 330 Employees.
- Kowa Pharmaceuticals America grew their employee count by -3% last year.
Kowa Pharmaceuticals America's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO & President | Reveal Email/Phone |
2 | CFO | Reveal Email/Phone |
3 | VP Trade/Business Development | Reveal Email/Phone |
4 | VP Regulatory & Business Operations | Reveal Email/Phone |
5 | VP HR | Reveal Email/Phone |
6 | VP Sales | Reveal Email/Phone |
7 | Director, Sales Operations | Reveal Email/Phone |
8 | Director, Sales Training & Development | Reveal Email/Phone |
9 | Chief Medical Officer | Reveal Email/Phone |
10 | Chief Commercial Officer | Reveal Email/Phone |
Kowa Pharmaceuticals America Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $18.9M | 94 | 4% | N/A | N/A |
#2 | $10.3M | 51 | -28% | N/A | N/A |
#3 | $44.8M | 223 | 7% | N/A | N/A |
#4 | $16.5M | 82 | -1% | N/A | N/A |
#5 | $26.7M | 133 | 4% | N/A | N/A |
#6 | $42M | 209 | -3% | N/A | N/A |
#7 | $1.4M | 14 | 8% | N/A | N/A |
#8 | $66.3M | 330 | -3% | N/A | N/A |
#9 | $13.9M | 69 | 1% | N/A | N/A |
#10 | $32.2M | 160 | -10% | N/A | N/A |
What Is Kowa Pharmaceuticals America?
Kowa Pharmaceuticals America, Inc. is a specialty pharmaceutical company focused primarily in the areas of cardiology, pain and migraine. A privately held pharmaceutical company headquartered in Montgomery, Alabama, we are focusing our efforts on the acquisition, development, licensing, and marketing of pharmaceutical products. Kowa's entry into the U.S. pharmaceutical market represents a significant step towards its vision of creating a global pharmaceutical organization. KPA is a specialty pharmaceutical company focused on delivering customer solutions for cardiovascular conditions. The privately held company focuses its efforts on the acquisition, development, licensing, and marketing of pharmaceutical products.
keywords:N/AN/A
Total Funding
330
Number of Employees
$66.3M
Revenue (est)
-3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Kowa Pharmaceuticals America News
Kowa Pharmaceuticals America. On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their...
... GlaxoSmithKline, Impax, Abbott, Bayer, Eli Lilly, Ethypharm, Kowa Pharmaceuticals America, Winston Pharmaceuticals, AstraZeneca.
Mylan Pharmaceuticals, Teva Pharmaceuticals, Kowa Pharmaceuticals America Inc., Novartis AG, Pfizer Inc., Astrazeneca Plc, Sun Pharmaceuticals...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $135.3M | 330 | 7% | N/A |
#2 | $104.7M | 342 | N/A | N/A |
#3 | $115.8M | 343 | 6% | N/A |
#4 | $75M | 372 | 20% | N/A |
#5 | $15M | 378 | 14% | N/A |